• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

I-SPY 2--Toward More Rapid Progress in Breast Cancer Treatment.

作者信息

Carey Lisa A, Winer Eric P

机构信息

From the Division of Hematology-Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill (L.A.C.); and the Breast Oncology Program, Dana-Farber Cancer Institute, Boston (E.P.W.).

出版信息

N Engl J Med. 2016 Jul 7;375(1):83-4. doi: 10.1056/NEJMe1603691.

DOI:10.1056/NEJMe1603691
PMID:27406352
Abstract
摘要

相似文献

1
I-SPY 2--Toward More Rapid Progress in Breast Cancer Treatment.I-SPY 2——迈向乳腺癌治疗的更快进展。
N Engl J Med. 2016 Jul 7;375(1):83-4. doi: 10.1056/NEJMe1603691.
2
SPINDLY is a nuclear-localized repressor of gibberellin signal transduction expressed throughout the plant.SPINDLY是一种在植物中普遍表达的赤霉素信号转导的核定位阻遏物。
Plant Physiol. 2002 Jun;129(2):605-15. doi: 10.1104/pp.020002.
3
SECRET AGENT and SPINDLY have overlapping roles in the development of Arabidopsis thaliana L. Heyn.SECRET AGENT和SPINDLY在拟南芥（Arabidopsis thaliana L. Heyn.）的发育过程中具有重叠作用。
J Exp Bot. 2006;57(4):865-75. doi: 10.1093/jxb/erj071. Epub 2006 Feb 10.
4
Functional analysis of SPINDLY in gibberellin signaling in Arabidopsis.拟南芥中SPINDLY在赤霉素信号传导中的功能分析
Plant Physiol. 2007 Feb;143(2):987-1000. doi: 10.1104/pp.106.091025. Epub 2006 Dec 1.
5
SPINDLY's role in the gibberellin response pathway.SPINDLY在赤霉素反应途径中的作用。
Symp Soc Exp Biol. 1998;51:73-8.
6
ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma.ETV6基因破坏并不能预测分泌性乳腺癌的惰性临床行为。
Breast J. 2012 Nov-Dec;18(6):604-6. doi: 10.1111/tbj.12041. Epub 2012 Oct 19.
7
Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.通过创新的RNA干扰疗法沉默PRDM14表达可抑制乳腺癌的干性、致瘤性和转移。
Oncotarget. 2017 Jul 18;8(29):46856-46874. doi: 10.18632/oncotarget.16776.
8
Cytosolic activity of SPINDLY implies the existence of a DELLA-independent gibberellin-response pathway.SPINDLY的胞质活性意味着存在一条不依赖DELLA的赤霉素反应途径。
Plant J. 2009 Jun;58(6):979-88. doi: 10.1111/j.1365-313X.2009.03840.x. Epub 2009 Feb 18.
9
Altered expression of SPINDLY affects gibberellin response and plant development.SPINDLY表达的改变影响赤霉素反应和植物发育。
Plant Physiol. 2001 Jul;126(3):1174-85. doi: 10.1104/pp.126.3.1174.
10
A commentary on Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.对非BRCA1/2法裔加拿大乳腺癌家族中ZNF350/ZBRK1启动子变异与乳腺癌易感性分析的评论
J Hum Genet. 2013 Feb;58(2):58. doi: 10.1038/jhg.2012.142. Epub 2012 Dec 6.

引用本文的文献

1
Implementation of statistical features of a Bayesian two-armed responsive adaptive randomization trial with post hoc analysis of time trend drift.具有事后时间趋势漂移分析的贝叶斯双臂响应式自适应随机试验统计特征的实施
J Biopharm Stat. 2024 Jun 7:1-15. doi: 10.1080/10543406.2024.2359149.
2
A Strategy Utilizing Protein-Protein Interaction Hubs for the Treatment of Cancer Diseases.利用蛋白质-蛋白质相互作用枢纽治疗癌症疾病的策略。
Int J Mol Sci. 2023 Nov 8;24(22):16098. doi: 10.3390/ijms242216098.
3
Rational combinations of targeted cancer therapies: background, advances and challenges.
靶向癌症治疗的合理组合：背景、进展与挑战
Nat Rev Drug Discov. 2023 Mar;22(3):213-234. doi: 10.1038/s41573-022-00615-z. Epub 2022 Dec 12.
4
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer.持续的表皮生长因子受体/ Kirsten 大鼠肉瘤病毒癌基因同源物/七分子相互作用蛋白通路激活驱动三阴性乳腺癌的化疗耐药和早期肿瘤复发。
Cancer Drug Resist. 2022 Jun 22;5(3):691-702. doi: 10.20517/cdr.2022.31. eCollection 2022.
5
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years.多柔比星-环磷酰胺新辅助化疗序贯每周紫杉醇治疗早期乳腺癌：单中心 200 例连续患者的回顾性分析，中位随访 9.5 年。
Breast Cancer Res Treat. 2022 Jun;193(3):597-612. doi: 10.1007/s10549-022-06598-0. Epub 2022 Apr 22.
6
Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.疫情期间及之后的临床试验设计：I-SPY COVID试验
Nat Med. 2022 Jan;28(1):9-11. doi: 10.1038/s41591-021-01617-x.
7
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials.肿瘤学精准医学主方案：克服随机临床试验的方法学问题
Life (Basel). 2021 Nov 17;11(11):1253. doi: 10.3390/life11111253.
8
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.甘尼单抗与二甲双胍联合标准新辅助治疗用于2/3期乳腺癌
NPJ Breast Cancer. 2021 Oct 5;7(1):131. doi: 10.1038/s41523-021-00337-2.
9
The Bayesian Design of Adaptive Clinical Trials.自适应临床试验的贝叶斯设计。
Int J Environ Res Public Health. 2021 Jan 10;18(2):530. doi: 10.3390/ijerph18020530.
10
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future.乳腺癌的新辅助化疗：过去、现在与未来
Breast Cancer (Auckl). 2020 Dec 16;14:1178223420980377. doi: 10.1177/1178223420980377. eCollection 2020.